Intracranial atherosclerosis: Cerebral angiography findings, clinical phenotypes, and associated risk factors in a retrospective study
Keywords:
intracranial atherosclerosis, large artery disease, ischemic stroke, hypertension, dyslipidemia, cerebral angiography, risk factors, clinical phenotypes, retrospective cohort studyAbstract
Background and Aim: Intracranial atherosclerosis (ICAS) is a significant contributor to global stroke incidence and is associated with a substantially higher risk of stroke recurrence compared to other stroke types. The annual recurrence rate of ischemic stroke in ICAS ranges from 10% to 50%, with a two-year recurrence rate of 38.2% in the affected arterial territory. Identifying the risk factors associated with ICAS is essential to improving prevention and management strategies.
Methods: This retrospective descriptive study analyzed medical records of ischemic stroke patients at Wahidin Sudirohusodo Hospital who underwent cerebral angiography from January 2021 to December 2022. Variables studied included demographic characteristics (age, sex), risk factors, and the location of ICAS within intracranial vessels.
Results: A total of 106 ICAS patients were identified during the study period. The majority were male (58.40%), with an average age of 54.7 years. The highest prevalence was observed in the 50–60 age group (45.28%). Hypertension was the most frequent risk factor (70.75%), followed by dyslipidemia (46.22%), diabetes mellitus (22.64%), prior stroke or transient ischemic attack (17.92%), extracranial carotid artery stenosis (7.54%), and cardiac disease (5.66%). The middle cerebral artery (MCA) was the most commonly affected site (57.46%).
Conclusions: Hypertension and dyslipidemia were the leading modifiable risk factors for ICAS, emphasizing the need for targeted management strategies. Effective control of these conditions could serve as a primary and secondary preventive approach to reduce ICAS incidence and associated complications. (www.actabiomedica.it)
References
Holmstedt CA, Turan TN, Chimowitz MI. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2013;12(11):1106-1114. doi:10.1016/S1474-4422(13)70195-9
Gutierrez J, Turan TN, Hoh BL, Chimowitz MI. Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment [published correction appears in Lancet Neurol. 2022 Apr;21(4): e4. doi: 10.1016/S1474-4422(22)00081-3]. Lancet Neurol. 2022;21(4):355-368. doi:10.1016/S1474-4422(21)00376-8
Han Y, Zhang R, Yang D, et al. Risk Factors for Asymptomatic and Symptomatic Intracranial Atherosclerosis Determined by Magnetic Resonance Vessel Wall Imaging in Chinese Population: A Case-Control Study. Ther Clin Risk Manag. 2022; 18:61-70. Published 2022 Jan 12. doi:10.2147/TCRM.S335401
Yang D, Cherian L, Arfanakis K, Schneider JA, Aggarwal NT, Gutierrez J. Intracranial atherosclerotic disease and neurodegeneration: a narrative review and plausible mechanisms. J Stroke Cerebrovasc Dis. 2024;33(12):108015. doi: 10.1016/j.jstrokecerebrovasdis.2024.108015
Banerjee C, Chimowitz MI. Stroke Caused by Atherosclerosis of the Major Intracranial Arteries. Circ Res. 2017;120(3):502-513. doi:10.1161/CIRCRESAHA.116.308441
Li HQ, Wang X, Wang HF, et al. Dose-response relationship between blood pressure and intracranial atherosclerotic stenosis. Atherosclerosis. 2021; 317:36-40. doi: 10.1016/j.atherosclerosis.2020.12.004
Li Z, Duan GX, Zhang JH, Xu Y, Luo Y. Blood Pressure Control for Patients with Middle Cerebral Artery Severe Stenosis or Occlusion. Clin Interv Aging. 2024; 19:1897-1905. Published 2024 Nov 18. doi:10.2147/CIA.S477281
Ma YH, Leng XY, Dong Y, et al. Risk factors for intracranial atherosclerosis: A systematic review and meta-analysis. Atherosclerosis. 2019; 281:71-77. doi: 10.1016/j.atherosclerosis.2018.12.015
Ke J, Li J, Chen J, et al. A Non-Linear Role of Hyperlipidemia on Progression of Intracranial Atherosclerotic Plaques and Acute Downstream Ischemic Events. J Atheroscler Thromb. 2023;30(10):1448-1460. doi:10.5551/jat.63971
Fujiyoshi A, Suri MFK, Alonso A, et al. Hyperglycemia, duration of diabetes, and intracranial atherosclerotic stenosis by magnetic resonance angiography: The ARIC-NCS study. J Diabetes Complications. 2020;34(9):107605. doi: 10.1016/j.jdiacomp.2020.107605
Jiao S, Huang J, Chen Y, et al. Impacts of Glycemic Control on Intracranial Plaque in Patients with Type 2 Diabetes Mellitus: A Vessel Wall MRI Study. AJNR Am J Neuroradiol. 2021;42(1):75-81. doi:10.3174/ajnr. A6878
Zhao M, Dong Y, Chen L, Shen H. Influencing factors of stroke in patients with type 2 diabetes: A systematic review and meta-analysis. PLoS One. 2024;19(6): e0305954. Published 2024 Jun 24. doi: 10.1371/journal.pone.0305954
Choi N, Lee JY, Sunwoo JS, et al. Recently Uncontrolled Glycemia in Diabetic Patients Is Associated with the Severity of Intracranial Atherosclerosis. J Stroke Cerebrovasc Dis. 2017;26(11):2615-2621. doi: 10.1016/j.jstrokecerebrovasdis.2017.06.025
Alqahtani SA, Abdulmutali HM, Alwabel HH, et al. Frequency, Risk Factors, and Outcomes of Intracranial Atherosclerotic Stenosis in Stroke Patients from the Southern Region of Saudi Arabia. Cureus. 2023;15(8): e43499. Published 2023 Aug 15. doi:10.7759/cureus.43499
Chaturvedi S, Turan TN, Lynn MJ, et al. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology. 2007;69(22):2063-2068. doi: 10.1212/01.wnl.0000279338.18776.26
Panagiotopoulos E, Stefanou MI, Magoufis G, et al. Prevalence, diagnosis and management of intracranial atherosclerosis in White populations: a narrative review. Neurol Res Pract. 2024;6(1):54. Published 2024 Nov 11. doi:10.1186/s42466-024-00341-4
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Muhammad Yunus Amran, Irbab Hawari, M Fajrin Hidayah
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
